中文 | ENG

第51卷 第4期 2018-8
Idiopathic isolated omental panniculitis presenting with intestinal obstruction

.........................

第51卷 第4期 2018-8
Heterotopic subserosal pancreatic tissue in jejunum

.........................

第51卷 第4期 2018-8
Surgical intervention of a giant gastric gastrointestinal stromal tumor following neoadjuvant therapy with imatinib

.........................

第51卷 第4期 2018-8
Surgical treatment for duodeno‑reno‑cutaneous fistula

.........................

第51卷 第4期 2018-8
Laparoscopic liver resection for polycystic liver disease

.........................

第51卷 第4期 2018-8
The result of emergency cardiac intervention in resuscitated out‑of‑hospital cardiac arrest patients

.........................

第51卷 第4期 2018-8
The use of perforator flaps for the reconstruction of sacral defects: Ten-year experience

.........................

第51卷 第4期 2018-8
Chloroquine induces lysosomal membrane permeabilitymediated cell death in bladder cancer cells

.........................

第51卷 第3期 2018-6
Emphysematous gastritis after radical subtotal gastrectomy for advanced gastric cancer

.........................

第51卷 第3期 2018-6
Primary cervical spine melanoma

.........................

第51卷 第3期 2018-6
Jejunostomy tube-induced intussusception

.........................

第51卷 第3期 2018-6
Adult‑onset neurocutaneous melanosis with Dandy–Walker malformation

.........................

第51卷 第3期 2018-6
Association between laboratory markers and oncological outcomes in patients with osteosarcoma – A review of osteosarcoma treatment in Indonesia

.........................

第51卷 第3期 2018-6
Thoracoscopic repair of esophageal atresia: Comparison with open approach

.........................

第51卷 第3期 2018-6
Hypotensive effect of labetalol and dexmedetomidine blood loss and surgical conditions in functional endoscopic sinus surgery: A double‑blind randomized clinical trial

.........................

第51卷 第3期 2018-6
Lessening hepatic injury in cholestatic liver by optimal dietary docosahexaenoic acid supplementation in rats

.........................

第51卷 第2期 2018-4
Abdominoscrotal hydrocele: A rare cause of a cystic abdominal mass in children

.........................

第51卷 第2期 2018-4
Management of hemodynamically unstable, ruptured multiple hepatic artery pseudoaneurysms by open surgery combined with endovascular embolization

.........................

第51卷 第2期 2018-4
Can female urethral calculus present with acute urinary retention?

.........................

第51卷 第2期 2018-4
Metachronous adenocarcinoma and large cell neuroendocrine carcinoma of the colon

.........................
登入帳號才能閱讀全文
 
篇名 Lessening hepatic injury in cholestatic liver by optimal dietary docosahexaenoic acid supplementation in rats
作者 Guan‑Yeu Diau, Shih‑Ming Kuo, Chieh‑Wen Lin
卷期/出版年月 51卷3期 (2018/6)
頁次 91-97
摘要 Background: Dietary adjuvant management for the cholestatic liver disease before/after surgery is an important clinical issue. This study investigated the possibility for the dietary supplementation of docosahexaenoic acid (DHA) to treat cholestasis liver through the bile duct ligation (BDL) rat model. Materials and Methods: Thirty‑six male Wistar rats were divided into four groups (N: no BDL; BL, 1P, 5P: received BDL) and consumed either a regular diet (N, BL) or of DHA‑enriched diet (1P: at 1% and 5P: at 5% weight percentage) for 4 weeks. The liver fatty acids (FAs) profiles, serum aspartate transaminase (AST), alanine aminotransferase (ALT), total bilirubin, alkaline phosphatase, interleukin‑2 (IL‑2), interferon γ (INF‑γ), and pathological examination with H and E, Masson, CD56 (natural killer cell), CD68 (macrophage) were examined. Results: The DHA dietary supplement increased liver DHA after BDL. Liver DHA N 8.09 ± 0.60% and BL 8.41 ± 0.55% were the lowest than the supplemented groups 1P 12.57 ± 1.16%, 5P 18.36 ± 2.00% (P = 0.000). However, liver arachidonic acid (20:4n‑6) 1P 23.13 ± 2.19% was the highest than N 18.86 ± 4.31%, BL 17.13 ± 3.07%, 5P 18.78 ± 1.76% (P = 0.001). The serum AST (U/L) in N 147.4 ± 28.2 and 1P 155.9 ± 35.1 were lower than B 317.1 ± 195.8, 5P 326.9 ± 141. 8 (P = 0.006). The serum alkaline phosphatase (U/L) showed the same trend N 49.8 ± 5.4, 1P 67.6 ± 21.1 were lower than the BL 172.2 ± 108.1, 5P 171.1 ± 149.1 (P = 0.017). Pathological examination with H and E, Masson revealed the fibrosis was prominent in BL, 5P. However, there were no significant differences in serum ALT, total bilirubin, IL‑2, INF‑γ, and immunohistochemical stain for the CD56, CD68. Conclusions: The results suggested that optimal dietary supplementing of DHA (1P) had less destruction and liver enzymes released after the BDL. However, higher enriched DHA (5P) could not benefit from this dietary treatment. The body weight did not increase even with this enriched high FAs diet after BDL for 4 weeks.
關鍵詞 Bile duct ligation, cholestasis liver disease, docosahexaenoic acid, hepatic injury
分類 Original Article

台灣外科醫學會雜誌 © 2006 Taiwan Surgical Association All Rights Reserved
會 址:台北市南京東路五段 31 號 3 樓
電 話:(02) 2769-7845 傳 真:(02) 2746-7149 Email: journal@24drs.com